Anti-sense approach to anticholinesterase therapeutics

Israel Medical Association Journal

Volumn 2, Issue SUPPL. JULY, 2000, Pages 81-85

  Soreq, H ^a   Seidman, S ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Anti sense; Cholinesterase inhibitors; Head injury; Myasthenia gravis; Stress

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANTISENSE OLIGONUCLEOTIDE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; PYRIDOSTIGMINE;

ALZHEIMER DISEASE; BIOSYNTHESIS; CHOLINERGIC SYNAPSE; CHOLINERGIC SYSTEM; CONFERENCE PAPER; DRUG HYDROLYSIS; DRUG INHIBITION; DRUG MECHANISM; DRUG SENSITIVITY; DRUG SPECIFICITY; DRUG TRANSPORT; HEAD INJURY; HUMAN; MOUSE; MYASTHENIA GRAVIS; NEUROMUSCULAR SYNAPSE; NEUROTRANSMISSION; NONHUMAN;

ACETYLCHOLINESTERASE; ALTERNATIVE SPLICING; ALZHEIMER DISEASE; CHOLINERGIC FIBERS; CHOLINESTERASE INHIBITORS; HUMANS; MYASTHENIA GRAVIS; OLIGONUCLEOTIDES, ANTISENSE; PROTEIN STRUCTURE, TERTIARY; RNA, MESSENGER; SYNAPTIC TRANSMISSION;

EID: 0033858930     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (47)

1. Antisense therapeutics: Is it as simple as complementary base recognition?
2. Antisense technologies have a future fighting neurodegenerative diseases
3. Use of antisense oligonucleotides in the central nervous system: Why such success?
4. Agents acting at the neuromuscular junction and autonomic ganglia
5. Engineering of human cholinesterases explains and predicts diverse consequences of administration of various drugs and poisons
6. Novel roles for cholinesterases in stress and inhibitor responses
7. Molecular cloning and construction of the coding region for human acetylcholinesterase reveals a G + C-rich attenuating structure
8. Genetic predisposition to adverse consequences of anti-cholinesterases in 'atypical' BCHE carriers
9. Promoter elements and alternative splicing in the human ACHE gene
10. Gene structure of mammalian acetylcholinesterase. Alternative exons dictate tissue-specific expression
11. Human erythrocyte but not brain acetylcholinesterase hydrolyses heroin to morphine
12. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response
13. Antisense prevention of neuronal damages following head injury in mice
14. Tracking cholinergic pathways from psychlogical and chemical stressors to variable neurodegeneration paradigms
15. The vicious circle: Long-lasting transcriptional modulation of cholinergic neurotransmission following stress and anticholinesterase exposure
16. Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired acetylcholinesterase-transgenic mice
17. Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice
18. Acetylcholinesterase-transgenic mice display embryonic modulations in spinal cord choline acetyltransferase and neurexin Ibeta gene expression followed by late-onset neuromotor deterioration
19. Excess 'readthrough' acetylcholinesterase attenuates but the 'synaptic' variant intensifies neurodeterioration correlates
20. A transcription-activating polymorphism in the ACHE promoter associated with acute sensitivity to anti-acetylcholinesterases
21. Differentiation intensifies the susceptibility of pheochromocytoma cells to antisense oligodeoxynucleotide-dependent suppression of acetylcholinesterase activity
22. Structural roles of acetylcholinesterase variants in biology and pathology
23. Acetylcholinesterase enhances neurite growth and synapse development through alternative contributions of its hydrolytic capacity, core protein, and variable C termini
24. The structure-function relationships in Drosophila neurotactin show that cholinesterasic domains may have adhesive properties
25. Structures, alternative splicing, and neurexin binding of multiple neuroligins
26. Functional redundancy of acetylcholinesterase and neuroligin in mammalian neuritogenesis
27. Antisense oligonucleotide inhibition of acetylcholinesterase gene expression induces progenitor cell expansion and suppresses hematopoietic apoptosis ex vivo
28. Antisense inhibition of acetylcholinesterase gene expression causes transient hematopoietic alterations in vivo
29. Immature human megakaryocytes produce nuclear-associated acetylcholinesterase
30. Manipulations of cholinesterase gene expression modulate murine mega-karyocytopoiesis in vitro
31. Use of partially phosphorothioated 'antisense' oligodeoxynucleotides for sequence-dependent modulation of hematopoiesis in culture
32. Human osteogenesis involves differentiation-dependent increases in the morphogenically active 3' alternative splicing variant of acetylcholinesterase
33. Molecular neurotoxicity implications of acetylcholinesterase inhibition
34. Is there a Gulf War Syndrome? Searching for syndromes by factor analysis of symptoms
35. Synaptogenesis and myopathy under acetylcholinesterase overexpression
36. Myasthenia gravis: Prototype of the antireceptor autoimmune diseases
37. A practical guide to the recognition and management of myasthenia gravis
38. Motor innervation of myasthenic muscles
39. Basic mechanisms of traumatic brain damage
40. Molecular biology of CNS injury
41. Neuropathology of the head injuries
42. Alzheimer's disease: A disorder of cortical cholinergic innervation
43. Cholinesterase inhibitors for Alzheimer's disease therapy: From tacrine to future applications
44. Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: Possible role of the peripheral site of the enzyme
45. Brain acetylcholinesterase promotes amyloid-beta-peptide aggregation but does not hydrolyze amyloid precursor protein peptides